Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer [Phase 1]
Phase 1 trial evaluating intraperitoneal cytokine-induced memory-like natural killer cells for recurrent ovarian cancer (including histologi…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Safety and Efficacy of Anti-CD47, ALX148 in Combination With Liposomal Doxorubicin and Pembrolizumab in Recurrent Platinum-resistant Ovarian Cancer [Phase 2]
Phase 2 trial evaluating the safety and efficacy of ALX148 in combination with liposomal doxorubicin and pembrolizumab for recurrent platinu…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer [Phase 2]
A Phase 2 clinical trial is evaluating tumor-infiltrating lymphocyte immunotherapy for multiple metastatic cancers and is currently recruiti…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy [Phase 2]
Phase 2 clinical trial evaluating whether tart cherry juice can prevent paclitaxel-induced neuropathy in patients with breast or ovarian can…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC [Phase 1, Phase 2]
First-in-human Phase 1/2 trial of the NaPi2b-targeted antibody-drug conjugate TUB-040 assessing safety, PK, and preliminary efficacy in pati…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Evaluation of Polygenic Risk Score for Epithelial OVarian cancEr Risk Prediction: the PROVE Study
This document reports an ongoing clinical trial (PROVE) evaluating a polygenic risk score to predict epithelial ovarian cancer risk.
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial [Phase 2]
Ongoing Phase 2 pilot clinical trial evaluating riluzole to prevent cognitive dysfunction in cancer patients undergoing chemotherapy, with m…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: IDOV-Immune for Advanced Solid Tumors [Phase 1]
This report summarizes a Phase 1 trial of IDOV-Immune from ViroMissile, Inc. for advanced solid tumors, which is currently recruiting across…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors [Phase 1, Phase 2]
AZD5335 is being studied in Phase 1/2a as both a single-agent therapy and in combination therapy for solid tumors, with recruitment ongoing.…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: D9319C00001- 1L OC Mono Global RCT [Phase 3]
Phase 3 global randomized trial of a monotherapy in first-line ovarian cancer is currently active but not recruiting. Sponsor: AstraZeneca.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: A Study of Second Look Laparoscopy (SLL) in People With Ovarian Cancer Who Have Completed Their First Course of Chemotherapy [Phase 2]
A Phase 2 clinical trial evaluating second-look laparoscopy in women with ovarian cancer after completing their first course of chemotherapy…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Characterization of Epithelial Ovarian Cancer Patients in Terms of Homologous Recombination Phenotype
This clinical trial update describes characterizing epithelial ovarian cancer patients by homologous recombination phenotype. The study is c…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: ASTRA Study: Circulating Tumor Cells in Blood of Patients With High-Grade Serous Ovarian Cancer [NA]
The ASTRA study, which investigates circulating tumor cells in the blood of patients with high-grade serous ovarian cancer, has completed.
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Esketamine for Prevention of Depression After Cytoreductive Surgery in Ovarian Cancer [NA]
This completed clinical trial assesses esketamine for prevention of depressive symptoms after cytoreductive surgery in patients with ovarian…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Olaparib, Durvalumab and UV1 in Relapsed Ovarian Cancer [Phase 2]
Phase 2 trial evaluating olaparib in combination with durvalumab and UV1 for relapsed ovarian cancer; the study is currently active but not …
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers. [Phase 2, Phase 3]
The DETERMINE trial's Arm 07 is studying dabrafenib plus trametinib in patients with BRAF V600 mutation-positive cancers across age groups; …
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Neoadjuvant Treatment of Ovarian Cancer With Fuzuloparib in Combination With Apatinib [Phase 2]
A Phase 2 trial is evaluating neoadjuvant therapy for ovarian cancer using the PARP inhibitor fuzuloparib in combination with apatinib. Recr…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: With Love, Grandma ("Con Cariño, Abuelita") Pilot Study [NA]
A pilot trial at the University of Miami Sylvester Comprehensive Cancer Center is recruiting for 'With Love, Grandma' (Con Cariño, Abuelita)…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: PRO1107 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
The Phase 1/2 PRO1107 trial in advanced solid tumors, including endometrial and ovarian cancers, has been terminated.
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Video Education With Result Dependent dIsclosure [NA]
A Dana-Farber Cancer Institute clinical trial update for a study on video education with result-dependent disclosure, currently recruiting, …
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery [EARLY_Phase 1]
An early-phase clinical trial is evaluating olaparib for newly diagnosed BRCA-mutant ovarian, fallopian tube, or primary peritoneal cancers …
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Navigation Intervention for Adolescent and Young Adult Cancer Survivors [NA]
A Kaiser Permanente-sponsored clinical trial update describes a navigation intervention for adolescent and young adult cancer survivors. The…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: ADP-A2M4CD8 Monotherapy and in Combination With Nivolumab in HLA-A2+ Subjects With MAGE-A4 Positive Ovarian Cancer (SURPASS-3) [Phase 2]
Phase 2 trial update for ADP-A2M4CD8 TCR therapy alone and in combination with nivolumab in HLA-A2+ MAGE-A4 positive ovarian cancer (SURPASS…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Artificial Intelligence - Assisted Model for Optimal Timing of Surgery in Advanced Ovarian Cancer
A clinical trial update from Shanghai Gynecologic Oncology Group describes an active-but-not-recruiting study evaluating an AI-assisted mode…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer [Phase 1]
This clinical trial update announces the first-in-human, Phase 1 study of ATX-295, an oral inhibitor of KIF18A, in patients with advanced or…